Corcept Therapeutics Competitors and Similar CompaniesClear all
Corcept Therapeutics's competitors and similar companies include Baylor Scott & White Research Institute, ASLAN Pharmaceuticals, BeyondSpring and Telix Pharmaceuticals.
 Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators. |  Baylor Scott & White Research Institute Baylor Scott & White Research Institute (BSWRI) is a research and development organization that studies population health, discovers new therapies, and conducts clinical trials. |  ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market. |  BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. |  Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care. | |
Founding Date | Founding Date 1998 | Founding Date 1903 | Founding Date N/A | Founding Date 2010 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Redwood City, US HQ | Locations Dallas, US HQ | Locations SG HQ Collingwood, AU | Locations Florham Park, US HQ | |
Employees | Employees 35218% increase | Employees 600 | Employees 35 | Employees 6712% decrease | Employees 415 |
Valuation ($) | Valuation ($) 5 b | Valuation ($) N/A | Valuation ($) 1.7 m | Valuation ($) 89.4 m | Valuation ($) 4.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $482.4m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $1.4m (FY, 2022) | Revenue (est.) $502.5m (FY, 2023) |
Cost of goods | Cost of goods $6.5m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $181.4m (FY, 2023) |
Gross profit | Gross profit $475.9m (FY, 2023) | Gross profit N/A | Gross profit $12m (FY, 2023) | Gross profit N/A | Gross profit $321.3m (FY, 2023) |
Net income | Net income $106.1m (FY, 2023) | Net income N/A | Net income ($44.2m) (FY, 2023) | Net income ($36.3m) (FY, 2022) | Net income $5.2m (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 80.1m | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 36.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Baylor Scott & White Research Institute
HQ
Dallas, US
Baylor Scott & White Research Institute (BSWRI) is a research and development organization that studies population health, discovers new therapies, and conducts clinical trials.
View companyASLAN Pharmaceuticals
HQ
SG
Employees
35
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
View companyBeyondSpring
HQ
Florham Park, US
Employees
67↓ 12% decrease
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
View companyTelix Pharmaceuticals
HQ
North Melbourne, AU
Employees
415
Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
View company